How Does United Therapeutics Corporation (UTHR) Stock Rank on Wall Street Thursday?

Thursday, January 06, 2022 12:43 PM | InvestorsObserver Analysts

Mentioned in this article

How Does United Therapeutics Corporation (UTHR) Stock Rank on Wall Street Thursday?

Wall Street is positive on United Therapeutics Corporation (UTHR). On average, analysts give UTHR a Strong Buy rating. The average price target is $235, which means analysts expect the stock to climb by 19.70% over the next twelve months. That average ranking earns UTHR an Analyst Rating of 63, which is better than 63% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating UTHR a Strong Buy today. Find out what this means to you and get the rest of the rankings on UTHR!

See Full UTHR Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With United Therapeutics Corporation Stock Today?

United Therapeutics Corporation (UTHR) stock is trading at $196.33 as of 12:37 PM on Thursday, Jan 6, a gain of $3.44, or 1.78% from the previous closing price of $192.89. The stock has traded between $189.86 and $196.42 so far today. Volume today is light. So far 173,725 shares have traded compared to average volume of 385,509 shares. Click Here to get the full Stock Report for United Therapeutics Corporation stock.